Safety and effectiveness of ferric carboxymaltose intravenous therapy in pediatric patients with chronic kidney disease

• Main Authors: Patricia Garcia-Ortega (Author), Ines Jimenez-Lozano (Author), Álejandro Cruz (Author), Aurora Fernandez Polo (Author), Mercedes Lopez (Author), Gema Ariceta (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Iron-deficiency anemia is the most common reason for worsening of the anemia characteristically seen in chronic kidney disease (CKD). Ferric carboxymaltose (FCM) is a macromolecular hydroxide ferric carbohydrate complex that allows high-dose iron to be administered parenterally for gradual, controll...